Reported 8 months ago
With the passage of the dual laws on regenerative medicine on June 16, 2024, exosomes have become the hottest trend in the biotech industry, attracting key players like former Health Minister Lin Jou-yen, renowned hematologist Dr. Chen Yao-chang, and Taiwan's leading biotech companies to invest. Exosome technology is revolutionizing the field with potential applications in disease treatment, drug delivery, and cosmetics. Taiwan is poised to join the global exosome market under the support of the new laws, with local companies already making significant advancements in research and development.
Source: YAHOO